PATENT CLAIM ANALYSIS

Application Number: 15776913
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "165000"]

Abstract:
The present invention relates to a pharmaceutical composition containing a poorly soluble drug, hyaluronic acid, and a fatty acid, and to a method for preparing the same. The pharmaceutical composition of the present application has excellent stability even for long-term storage and allows a sustained release of the drug, thereby preventing an overdose of the drug and improving the therapeutic efficiency at an effected area.

Claim (Index 8):
The pharmaceutical composition of  claim 1 , wherein the poorly soluble drug or the pharmaceutically acceptable salt thereof, the hyaluronic acid or the pharmaceutically acceptable salt thereof, and the C8 to C26 aliphatic hydrocarbon derivative or the salt thereof are included at 1 to 10 parts by weight, 7 to 70 parts by weight, and 14 to 140 parts by weight, respectively.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.61364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13326477', '10511707', '10571005', '13825552', '12746754']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7370917358949589
- 35 USC 102 Novelty (BERT): 0.4964613062621061
- Combined Prediction Score: 0.7130286929316736
- Mean Citation Score: 202.93644
- Max Citation Score: 209.82545
- Similarity Product: 153.54457796218398

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test